selected publications
-
TOX is a critical regulator of tumour-specific T cell differentiation.
Nature.
2019
Academic Article
GET IT
Times cited: 495 -
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study.
Breast cancer research : BCR.
2018
Academic Article
GET IT
Times cited: 8 -
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.
Frontiers in cell and developmental biology.
2018
Review
GET IT
Times cited: 833 -
Checkpoint Inhibitors in the Treatment of Breast Cancer.
Current oncology reports.
2018
Review
GET IT
Times cited: 11 -
Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.
Cancer.
2018
Academic Article
GET IT
Times cited: 58 - Reply to L.B. Marks et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Letter GET IT
-
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Review
GET IT
Times cited: 130 -
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
2016
GET IT
Times cited: 74 -
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
2016
GET IT
Times cited: 117 -
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 128 -
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study.
Breast cancer research and treatment.
2016
Academic Article
GET IT
Times cited: 28 -
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients.
NPJ breast cancer.
2016
Academic Article
GET IT
Times cited: 19 -
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites.
NPJ breast cancer.
2015
Academic Article
GET IT
Times cited: 27 -
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
Clinical breast cancer.
2015
Academic Article
GET IT
Times cited: 1 -
Somatic mutations in leukocytes infiltrating primary breast cancers.
NPJ breast cancer.
2015
Academic Article
GET IT
Times cited: 21 -
The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.
European radiology.
2013
Academic Article
GET IT
Times cited: 29 -
Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer.
Journal of mammary gland biology and neoplasia.
2012
Review
GET IT
Times cited: 12 -
Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer.
Discovery medicine.
2012
Review
GET IT
Times cited: 31 -
Self-seeding in cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
2012
Review
GET IT
Times cited: 28 -
Tumor entrained neutrophils inhibit seeding in the premetastatic lung.
Cancer cell.
2011
Academic Article
GET IT
Times cited: 535 -
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2011
Editorial Article
GET IT
Times cited: 37 -
Clinical implications of cancer self-seeding.
Nature reviews. Clinical oncology.
2011
Review
GET IT
Times cited: 231 -
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
Breast cancer research and treatment.
2011
Academic Article
GET IT
Times cited: 82 -
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.
Genes & development.
2011
Academic Article
GET IT
Times cited: 185 -
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women.
Breast cancer research and treatment.
2010
Academic Article
GET IT
Times cited: 15 -
Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines.
Clinical breast cancer.
2010
Review
GET IT
Times cited: 6 -
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer.
Oncology (Williston Park, N.Y.).
2010
Review
GET IT
Times cited: 34 -
Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer.
Cancer journal (Sudbury, Mass.).
2010
Review
GET IT
Times cited: 48 -
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses.
American journal of obstetrics and gynecology.
2004
Academic Article
GET IT
Times cited: 20